Patent · US Active

Treatment and prevention of remote ischemia-reperfusion injury

US10286047B2 · kind B2 · utility

9Cited by

14References

10Claims

0Family size

Assignees

CSL Behring AG · DE
UNIVERSITAT BERN · CH

Inventors

Rolf SPIRIG · Bern, CH
Sylvia Miescher · Bern, CH
Marc Nolte · Marburg, DE
Claudia Duehrkop-Sisewitsch · Knivsta, SE
Robert Rieben · Hinterkappelen, CH

Key dates

Filing date	Mar 7, 2014
Grant date	May 14, 2019
Priority date	—
Expiry date	Mar 7, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/745
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a contact activation system inhibitor, preferably a C1INH, for use in the treatment and/or prevention of remote ischemia-reperfusion injury (IRI), comprising administering the contact activation system inhibitory to an individual.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.